CryoLife, Inc. CRY, an implantable biological medical device and cardiovascular tissue processing company, today announced the final results of its tender offer, including proration results, through its wholly owned subsidiary CL Falcon,
Inc., for 49.9 percent of the outstanding shares of Cardiogenesis Corporation ("Cardiogenesis") CGCP. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on Monday, May 2, 2011.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in